Pulcet 40 mg 14 tablets — Made in Turkey — Free Delivery

Duodenal ulcers usually take 2 weeks to treat. If this is not enough, a cure can be expected within the next 2 weeks.

Treatment of Zollinger-Ellison syndrome and other hypersecretory pathological conditions. For long-term treatment of Zollinger-Ellison syndrome and other pathological hypersecretory conditions, the initial daily dose is 80 mg (2 Pulcet tablets, 40 mg each). If necessary, then the dose can be titrated, increasing or decreasing, depending on the rate of acid secretion in the stomach. If the dose exceeds 80 mg / day, it must be divided into 2 doses. A temporary increase in the dose to more than 160 mg of pantoprazole is possible, but the duration of use should be limited only by the period necessary for adequate control of acid secretion.

The duration of treatment for Zollinger-Ellison syndrome and other pathological conditions is not limited and depends on the clinical need.

Patients with severely impaired liver function should not exceed a daily dose of 20 mg (1 tablet Pulcet 20 mg). Patients with moderate to severe hepatic dysfunction should not use the preparation Pulcet  for the eradication of H. pylori in combination therapy, since there is currently no data on the efficacy and safety of such use in this category of patients.

No dose adjustment is required for patients with impaired renal function. Patients with impaired renal function should not use the preparation Pulcet for the eradication of H. pylori in combination therapy, since there is currently no data on the efficacy and safety of such use for this category of patients.

Elderly patients do not need dose adjustment.

Hypersensitivity to pantoprazole or any component of the preparation.

The occurrence of adverse reactions was noted in about 5% of patients. the most common adverse reactions are diarrhea and headache (about 1%).

On the part of the blood and lymphatic system: agranulocytosis, leukopenia, thrombocytopenia, pancytopenia.

From the immune system: hypersensitivity reactions (including anaphylactic reactions, anaphylactic shock).

Metabolism and metabolic disorders: hyperlipidemia and increased lipid levels (TG, CS), changes in body weight, hyponatremia, hypomagnesemia.

Mental disorders: sleep disturbances, depression (with complications), disorientation (with complications), hallucinations; confusion (especially in patients with a tendency to these disorders, as well as exacerbation of these symptoms, if any).

From the nervous system: headache, dizziness, taste disorders.

From the side of the organ of vision: visual impairment / blurredness.

From the digestive tract: diarrhea, nausea, vomiting, bloating, constipation, dry mouth, abdominal pain and discomfort.

From the hepatobiliary system: an increase in the level of liver enzymes (transaminases, gamma-glutamyltransferase), an increase in the level of bilirubin, damage to hepatocytes, jaundice, hepatocellular insufficiency.

Skin and subcutaneous tissue disorders: skin rash, exanthema, pruritus, urticaria, angioedema, Stevens-Johnson syndrome, Lyell's syndrome, erythema multiforme, photosensitivity.

From the musculoskeletal system and connective tissue: arthralgia, myalgia.

On the part of the kidneys and urinary system: interstitial nephritis.

On the part of the reproductive system and mammary glands: gynecomastia.

General disorders: asthenia, fatigue, malaise, fever, peripheral edema.